These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 5316911)
1. Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects. Cabasso VJ; Loofbourow JC; Roby RE; Anuskiewicz W Bull World Health Organ; 1971; 45(3):303-15. PubMed ID: 5316911 [TBL] [Abstract][Full Text] [Related]
2. Serovaccination by human immune globulin and HDCS-vaccine against rabies. Kuwert EK; Werner J; Marcus I; Cabasso VJ Dev Biol Stand; 1978; 40():129-36. PubMed ID: 680386 [TBL] [Abstract][Full Text] [Related]
3. Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man. Nicholson KG; Turner GS Dev Biol Stand; 1978; 40():115-20. PubMed ID: 680384 [TBL] [Abstract][Full Text] [Related]
4. Rabies immune globulin (human) in the prevention of rabies. Cabasso VJ Am J Hosp Pharm; 1976 Jan; 33(1):48-51. PubMed ID: 773177 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744 [TBL] [Abstract][Full Text] [Related]
6. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related]
7. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. 4. Atanasiu P; Dean DJ; Habel K; Kaplan MM; Koprowski H; Lépine P; Serié C Bull World Health Organ; 1967; 36(3):361-5. PubMed ID: 5299668 [TBL] [Abstract][Full Text] [Related]
8. Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine. Archer BG; Dierks RE Bull World Health Organ; 1968; 39(3):407-17. PubMed ID: 5303907 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination. Wiktor TJ; Lerner RA; Koprowski H Bull World Health Organ; 1971; 45(6):747-53. PubMed ID: 5317010 [TBL] [Abstract][Full Text] [Related]
10. Rapidity and magnitude of antibody response to duck-embryo rabies vaccine administered as a pre-exposure regimen. Schnurrenberger PR; Anderson GR; Russell JH Bull World Health Organ; 1967; 37(4):547-51. PubMed ID: 5301735 [TBL] [Abstract][Full Text] [Related]
11. Human antirabies gamma globulin. HOSTY TS; KISSLING RE; SCHAEFFER M; WALLACE GA; DIBBLE EH Bull World Health Organ; 1959; 20(6):1111-9. PubMed ID: 14403320 [TBL] [Abstract][Full Text] [Related]
12. Human rabies globulin and human diploid vaccine dose determinations. Hafkin B; Alls ME; Baer GM Dev Biol Stand; 1978; 40():121-7. PubMed ID: 680385 [TBL] [Abstract][Full Text] [Related]
13. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Sikes RK; Cleary WF; Koprowski H; Wiktor TJ; Kaplan MM Bull World Health Organ; 1971; 45(1):1-11. PubMed ID: 5004004 [TBL] [Abstract][Full Text] [Related]
14. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. II. ATANASIU P; BAHMANYAR M; BALTAZARD M; FOX JP; HABEL K; KAPLAN MM; KISSLING RE; KOMAROV A; KOPROWSKI H; LEPINE P; PEREZ GALLARDO F; SCHAEFFER M Bull World Health Organ; 1957; 17(6):911-32. PubMed ID: 13511138 [TBL] [Abstract][Full Text] [Related]
15. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
16. [Pre- and post-infection rabies immunization: development of neutralizing antibodies after administration of different doses of a duck-egg vaccine in humans]. Kuwert E; Marcus I; Thraenhart O; Staudacher H Dtsch Med Wochenschr; 1972 Dec; 97(49):1893-8. PubMed ID: 4674033 [No Abstract] [Full Text] [Related]
17. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group. Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840 [TBL] [Abstract][Full Text] [Related]
18. Serum neutralizing antibody after rabies postexposure prophylaxis. Corey L; Hattwick MA; Baer GM; Smith JS Ann Intern Med; 1976 Aug; 85(2):170-6. PubMed ID: 945973 [TBL] [Abstract][Full Text] [Related]
19. [Immunogenicity of a new, highly purified, highly concentrated duck-embryo rabies vaccine]. Keller H; Glück R; Wegmann A; Wandeler AI Schweiz Med Wochenschr; 1984 May; 114(19):648-53. PubMed ID: 6740281 [TBL] [Abstract][Full Text] [Related]
20. Humoral immunity conferred by the HDCS rabies vaccine Mérieux administered after exposure: 151 cases with and without specific immune globulin of human origin. Preliminary communication. Méan F; Steck F; Tanner F Dev Biol Stand; 1978; 40():159-61. PubMed ID: 680389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]